APA (7th ed.) Citation

Ng, K., Lau, Y., Dhandhania, V., Cai, Z., Lee, Y., Lai, W., . . . Siu, C. (2018). Empagliflozin Ammeliorates High Glucose Induced-Cardiac Dysfuntion in Human iPSC-Derived Cardiomyocytes. Nature Portfolio.

Chicago Style (17th ed.) Citation

Ng, Kwong-Man, Yee-Man Lau, Vidhu Dhandhania, Zhu-Jun Cai, Yee-Ki Lee, Wing-Hon Lai, Hung-Fat Tse, and Chung-Wah Siu. Empagliflozin Ammeliorates High Glucose Induced-Cardiac Dysfuntion in Human IPSC-Derived Cardiomyocytes. Nature Portfolio, 2018.

MLA (8th ed.) Citation

Ng, Kwong-Man, et al. Empagliflozin Ammeliorates High Glucose Induced-Cardiac Dysfuntion in Human IPSC-Derived Cardiomyocytes. Nature Portfolio, 2018.